Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Cell Transplantation
and you are
under 28
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The objective of this study is to evaluate the efficacy and safety of a single intraventricular administration of Pneumostem® for treatment of Intraventricular hemorrhage (IVH) in high-risk premature infants by comparing Pneumostem-treated group with a control group.

Provided treatments

  • Drug: Pneumostem
  • Drug: Normal saline
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02890953. The sponsor of the trial is Samsung Medical Center and it is looking for 22 volunteers for the current phase.
Official trial title:
Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of IVH in Premature Infants (Phase 2a)